Funded Grants

One percent of Alzheimer’s disease is the early-onset type that runs in families.

Noninvasive brain stimulation is gaining acceptance as an alternate therapy for an increasing number of disorders, including major depression, schizophrenia, stroke and Parkinson’s disease.

500,000 Canadians have dementia, a number that will double within a generation due to the ongoing aging demographics of the population, with annual costs estimated to increase from $15B currently to over $150B by the year 2050.

Ms. Nancy Butcher, is a doctoral candidate who is conducting research using advanced brain imaging techniques to measure levels of the brain chemical dopamine, to differentiate between Parkinson’s disease and other motor neuron defects.

The CIFAR Learning in Machines & Brains program brings together 41 researchers to examine what consciousness is and how it comes about.

The CIFAR Humans & the Microbiome program brings together 21 researchers to examine what consciousness is and how it comes about.

The Azrieli Program in Brain, Mind & Consciousness brings together 22 researchers to examine what consciousness is and how it comes about.

Dr. De Koninck studies the persistent changes in spinal cord function that occur after nervous system injury that lead to chronic pain.

Complex research questions in neurology are often most effectively addressed by monitoring brain structure and function in human patients and live animals in experimental disease models.

There are an estimated 86,000 people living with a spinal cord injury (SCI) in Canada, with an annual economic burden of $2.67 billion for those surviving the initial injury.